Charles River Laboratories International Inc [CRL] stock prices are up 3.93% to $175.92 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CRL shares have gain 6.42% over the last week, with a monthly amount glided 6.06%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Charles River Laboratories International Inc [NYSE: CRL] stock has seen the most recent analyst activity on March 04, 2025, when Citigroup upgraded its rating to a Neutral and also boosted its price target to $175 from $155. Previously, Redburn Atlantic upgraded its rating to Neutral on March 03, 2025, and kept the price target unchanged to $188. On January 22, 2025, downgrade downgraded it’s rating to Mkt Perform. UBS downgraded its rating to a Neutral and decreased its price target to $185 on January 17, 2025. CLSA downgraded its rating to a Underperform but $164 remained the price target by the analyst firm on November 18, 2024. CLSA upgraded its rating to Hold for this stock on November 07, 2024, but kept the price target unchanged to $205. In a note dated October 23, 2024, CLSA initiated an Underperform rating and provided a target price of $167 on this stock.
The stock price of Charles River Laboratories International Inc [CRL] has been fluctuating between $150.79 and $275.00 over the past year. Currently, Wall Street analysts expect the stock to reach $188.67 within the next 12 months. Charles River Laboratories International Inc [NYSE: CRL] shares were valued at $175.92 at the most recent close of the market. An investor can expect a potential return of 7.25% based on the average CRL price forecast.
Analyzing the CRL fundamentals
The Charles River Laboratories International Inc [NYSE:CRL] reported sales of 4.05B for trailing twelve months, representing a drop of -1.08%. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.0 and Total Capital is 0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 170.26 points at the first support level, and at 164.61 for the second support level. However, for the 1st resistance point, the stock is sitting at 179.41, and for the 2nd resistance point, it is at 182.90.
Ratios To Look Out For
It’s worth pointing out that Charles River Laboratories International Inc [NYSE:CRL]’s Current Ratio is 1.41. Also, the Quick Ratio is 1.13, while the Cash Ratio stands at 0.2. Considering the valuation of this stock, the price to sales ratio is 2.22, the price to book ratio is 2.60 and price to earnings (TTM) ratio is 685.85.
Transactions by insiders
Recent insider trading involved FOSTER JAMES C, Chairman, President and CEO, that happened on Feb 20 ’25 when 6075.0 shares were purchased. Corporate Executive VP & COO, Girshick Birgit completed a deal on Feb 20 ’25 to buy 1514.0 shares. Meanwhile, EVP, Corp Strategy & Develop LaPlume Joseph W sold 4400.0 shares on Feb 20 ’25.
